FDA grants Jacobus Pharma approval for rare disease drug

Jacobus Pharmaceutical Co Inc on Monday won U.S. approval for the first drug to treat children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder.

from Reuters: Health https://reut.rs/2YcBBJU
via IFTTT

• Tweet
• Share
• Share
• Share
• Share